Citation analysis did not provide a reliable assessment of core outcome set uptake

被引:16
作者
Barnes, Karen L. [1 ]
Kirkham, Jamie J. [1 ]
Clarke, Mike [2 ]
Williamson, Paula R. [1 ]
机构
[1] Univ Liverpool, Dept Biostat, MRC North West Hub Trials Methodol Res, Block F Waterhouse Bldg,1-5 Brownlow St, Liverpool L69 3GL, Merseyside, England
[2] Queens Univ Belfast, Royal Victoria Hosp, Sch Med Dent & Biomed Sci, Ctr Publ Hlth,Inst Clin Sci, Block B,Grosvenor Rd, Belfast BT12 6BA, Antrim, North Ireland
关键词
Core outcome set; Uptake; Citation analysis; Clinical trials; Systemic sclerosis; Rheumatoid arthritis; Eczema; Sepsis and critical care; Female sexual dysfunction; CLINICAL-TRIALS; PATIENT PERSPECTIVE; DISEASE-ACTIVITY; END-POINTS; CONSENSUS; GUIDELINES;
D O I
10.1016/j.jclinepi.2017.03.003
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: The aim of the study was to evaluate citation analysis as an approach to measuring core outcome set (COS) uptake, by assessing whether the number of citations for a COS report could be used as a surrogate measure of uptake of the COS by clinical trialists. Study Design and Setting: Citation data were obtained for COS reports published before 2010 in five disease areas (systemic sclerosis, rheumatoid arthritis, eczema, sepsis and critical care, and female sexual dysfunction). Those publications identified as a report of a clinical trial were examined to identify whether or not all outcomes in the COS were measured in the trial. Results: Clinical trials measuring the relevant COS made up a small proportion of the total number of citations for COS reports. Not all trials citing a COS report measured all the recommended outcomes. Some trials cited the COS reports for other reasons, including the definition of a condition or other trial design issues addressed by the COS report. Conclusion: Although citation data can be readily accessed, it should not be assumed that the citing of a COS report indicates that a trial has measured the recommended COS. Alternative methods for assessing COS uptake are needed. (C) 2017 The Authors. Published by Elsevier Inc.
引用
收藏
页码:153 / 159
页数:7
相关论文
共 28 条
  • [1] Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications
    Basson, R
    Berman, J
    Burnett, A
    Derogatis, L
    Ferguson, D
    Fourcroy, J
    Goldstein, I
    Graziottin, A
    Heiman, J
    Laan, E
    Leiblum, S
    Padma-Nathan, H
    Rosen, R
    Segraves, K
    Segraves, RT
    Shabsigh, R
    Sipski, M
    Wagner, G
    Whipple, B
    [J]. JOURNAL OF UROLOGY, 2000, 163 (03) : 888 - 893
  • [2] How well are the ASAS/OMERACT Core Outcome Sets for Ankylosing Spondylitis implemented in randomized clinical trials? A systematic literature review
    Bautista-Molano, Wilson
    Navarro-Compan, Victoria
    Landewe, Robert B. M.
    Boers, Maarten
    Kirkham, Jamie J.
    van der Heijde, Desiree
    [J]. CLINICAL RHEUMATOLOGY, 2014, 33 (09) : 1313 - 1322
  • [3] BOERS M, 1994, J RHEUMATOL, V21, P86
  • [4] BOMBARDIER C, 1982, J RHEUMATOL, V9, P798
  • [5] Core outcome sets and trial registries
    Clarke, Mike
    Williamson, Paula
    [J]. TRIALS, 2015, 16
  • [6] Appraising the uptake and use of recommendations for a common outcome data set for clinical trials: a case study in fall injury prevention
    Copsey, Bethan
    Hopewell, Sally
    Becker, Clemens
    Cameron, Ian D.
    Lamb, Sarah E.
    [J]. TRIALS, 2016, 17
  • [7] Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses
    Falagas, Matthew E.
    Pitsouni, Eleni I.
    Malietzis, George A.
    Pappas, Georgios
    [J]. FASEB JOURNAL, 2008, 22 (02) : 338 - 342
  • [8] THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY CORE SET OF DISEASE-ACTIVITY MEASURES FOR RHEUMATOID-ARTHRITIS CLINICAL-TRIALS
    FELSON, DT
    ANDERSON, JJ
    BOERS, M
    BOMBARDIER, C
    CHERNOFF, M
    FRIED, B
    FURST, D
    GOLDSMITH, C
    KIESZAK, S
    LIGHTFOOT, R
    PAULUS, H
    TUGWELL, P
    WEINBLATT, M
    WIDMARK, R
    WILLIAMS, HJ
    WOLFE, F
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (06): : 729 - 740
  • [9] FRIED BJ, 1993, J RHEUMATOL, V20, P548
  • [10] Choosing Important Health Outcomes for Comparative Effectiveness Research: A Systematic Review
    Gargon, Elizabeth
    Gurung, Binu
    Medley, Nancy
    Altman, Doug G.
    Blazeby, Jane M.
    Clarke, Mike
    Williamson, Paula R.
    [J]. PLOS ONE, 2014, 9 (06):